Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Morphotek Inc.

No longer exists

Information

Organization's Own Description:

Morphotek, Inc. is a biopharmaceutical company focused on the discovery and development of therapeutic monoclonal antibodies (mAbs) for the treatment of cancer, inflammatory and infectious diseases. Morphotek develops these antibodies through the use of its proprietary human antibody technologies, Human MORPHODOMA® and Libradoma™.

As a wholly owned subsidiary of Eisai Co., Morphotek is now positioned to accelerate the development of its therapeutic antibody pipeline, as well as develop a number of additional clinical compounds.

Address:

Subscribers to LegiStorm Pro see the full address information for Morphotek Inc.. Click here to see more LegiStorm Pro benefits and subscribe, or to your Pro account.

Earmarks

Morphotek Inc. is the recipient of earmarks in the federal government budget. In this section, LegiStorm Pro users can see summaries of those earmarks. Click here to see more LegiStorm Pro benefits and subscribe, or to your Pro account.

Lobbying and Foreign Representation

Morphotek Inc. has lobbied the U.S. government. LegiStorm Pro users can see summaries of that lobbying activity. Click here to see more LegiStorm Pro benefits and subscribe, or to your Pro account.

Related Entities